ClinicalTrials.govpublic full text
Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2
severe acute respiratory syndrome coronavirus 2, metabolic syndrome, type 2 diabetes, sars-cov 2, severe acute respiratory syndrome, metformin glycinate, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807446
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.